FDA clears safety test to screen Tysabri patients
Friday, January 20, 2012 - 18:00
in Health & Medicine
(AP) -- The Food and Drug Administration on Friday approved a new diagnostic test to help identify patients who have an increased risk of developing a rare brain infection while taking Biogen Idec's multiple sclerosis drug Tysabri.